ATE306279T1 - Verwendung von uk114 für die behandlung von leishmaniasis - Google Patents
Verwendung von uk114 für die behandlung von leishmaniasisInfo
- Publication number
- ATE306279T1 ATE306279T1 AT03732475T AT03732475T ATE306279T1 AT E306279 T1 ATE306279 T1 AT E306279T1 AT 03732475 T AT03732475 T AT 03732475T AT 03732475 T AT03732475 T AT 03732475T AT E306279 T1 ATE306279 T1 AT E306279T1
- Authority
- AT
- Austria
- Prior art keywords
- leishmaniasis
- treatment
- ubiquitin
- humans
- animals
- Prior art date
Links
- 208000004554 Leishmaniasis Diseases 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 102000044159 Ubiquitin Human genes 0.000 abstract 1
- 108090000848 Ubiquitin Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002MI001205A ITMI20021205A1 (it) | 2002-06-04 | 2002-06-04 | Uso di proteine per il trattamento della leishmaniosi |
| PCT/EP2003/005551 WO2003101477A1 (en) | 2002-06-04 | 2003-05-27 | Use of uk114 in the treatment of leishmaniasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE306279T1 true ATE306279T1 (de) | 2005-10-15 |
Family
ID=11450033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03732475T ATE306279T1 (de) | 2002-06-04 | 2003-05-27 | Verwendung von uk114 für die behandlung von leishmaniasis |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20060100142A1 (de) |
| EP (1) | EP1511510B1 (de) |
| JP (1) | JP2005529932A (de) |
| AT (1) | ATE306279T1 (de) |
| AU (1) | AU2003238407A1 (de) |
| BR (1) | BR0311596A (de) |
| DE (1) | DE60301886D1 (de) |
| IT (1) | ITMI20021205A1 (de) |
| MX (1) | MXPA04012050A (de) |
| WO (1) | WO2003101477A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024074870A1 (es) * | 2022-10-06 | 2024-04-11 | Instituto Politecnico Nacional | Composición veterinaria de péptidos para inmunoterapia |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1290828B1 (it) * | 1997-03-25 | 1998-12-11 | Zetesis Spa | Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche |
| IT1298442B1 (it) * | 1998-02-24 | 2000-01-10 | Zetesis Spa | Composizioni orali a basso dosaggio di proteine citotossiche |
| ITMI991384A1 (it) * | 1999-06-22 | 2000-12-22 | Zetesis Spa | Uso della proteina uk 114 per inibire il rigetto dei trapianti d'organo |
-
2002
- 2002-06-04 IT IT2002MI001205A patent/ITMI20021205A1/it unknown
-
2003
- 2003-05-27 EP EP03732475A patent/EP1511510B1/de not_active Expired - Lifetime
- 2003-05-27 AT AT03732475T patent/ATE306279T1/de not_active IP Right Cessation
- 2003-05-27 DE DE60301886T patent/DE60301886D1/de not_active Expired - Lifetime
- 2003-05-27 WO PCT/EP2003/005551 patent/WO2003101477A1/en not_active Ceased
- 2003-05-27 BR BR0311596-8A patent/BR0311596A/pt not_active Application Discontinuation
- 2003-05-27 JP JP2004508832A patent/JP2005529932A/ja active Pending
- 2003-05-27 MX MXPA04012050A patent/MXPA04012050A/es unknown
- 2003-05-27 US US10/516,465 patent/US20060100142A1/en not_active Abandoned
- 2003-05-27 AU AU2003238407A patent/AU2003238407A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1511510B1 (de) | 2005-10-12 |
| EP1511510A1 (de) | 2005-03-09 |
| ITMI20021205A1 (it) | 2003-12-04 |
| ITMI20021205A0 (it) | 2002-06-04 |
| AU2003238407A1 (en) | 2003-12-19 |
| WO2003101477A1 (en) | 2003-12-11 |
| BR0311596A (pt) | 2005-04-26 |
| DE60301886D1 (de) | 2006-02-23 |
| US20060100142A1 (en) | 2006-05-11 |
| JP2005529932A (ja) | 2005-10-06 |
| MXPA04012050A (es) | 2005-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0011838A (pt) | Elementos misturadores estáticos empilhados | |
| CY1115745T1 (el) | Συνθεσεις και μεθοδοι για αντιμετωπιση ή προληψη σχετιζομενης με οξαλικα νοσου | |
| DE60218493D1 (de) | Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten | |
| ATE489957T1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
| ATE374196T1 (de) | Dihydrobenzodiazepin-2-on-derivative für die behandlung von neurologischen erkrankungen | |
| DE60329123D1 (de) | Benzoädüazepinderivate für die behandlung von neurologischen krankheiten | |
| CY1113306T1 (el) | Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6 | |
| DK1408984T3 (da) | Organofosforforbindelser til aktivering af gamma/delta T celler | |
| ATE418554T1 (de) | 1-acyl-pyrrolidin-derivate für die behandlung von viralen infektionen | |
| ATE502642T1 (de) | Kombinationen für die behandlung von immun- entzündlichen erkrankungen | |
| ATE422498T1 (de) | Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems | |
| ATE417616T1 (de) | Behandlung von mukositis | |
| ATE413399T1 (de) | Morpholinyl-harnstoff-derivative fuer die behandlung von krankheiten verbunden mit entzuendlichen prozessen | |
| ATE451921T1 (de) | Phenylindole zur behandlung von hiv | |
| DK1539724T3 (da) | Aminobenzothiazolforbindelser med NOS-inhiberende aktivitet | |
| NO20055741D0 (no) | Nye kjemiske forbindelser | |
| DE602004023721D1 (de) | Zusammensetzungen und methoden für die behandlung von herzerkrankungen | |
| EA200501528A1 (ru) | Применение кластерина для лечения и/или профилактики периферических неврологических заболеваний | |
| DE60230455D1 (de) | Natürliche verbindung für die behandlung von diabetes, deren herstellung und verwendung | |
| DE60325496D1 (de) | Verwendung von dihydroimidazolonen zur behandlung von epilepsie bei hunden | |
| ATE406171T1 (de) | Aplidine zur behandlung von multiplem myelom | |
| DE60301886D1 (de) | Verwendung von uk114 für die behandlung von leishmaniasis | |
| DE50308032D1 (de) | Isoliertes fluoreszierendes protein aus clytia gregaria cgfp, sowie dessen verwendung | |
| ATE277924T1 (de) | Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression | |
| ATA18172002A (de) | Rahmen für sessel, insbesondere von sesselliften |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |